Schering back in good graces
Executive Summary
Schering-Plough completed all 212 significant steps and 30 validation actions required under its manufacturing consent decree by its deadline of Dec. 31, 2005. The goal was reached on time, as the company had anticipated (1"The Pink Sheet" Nov. 14, 2005, p. 28). The consent decree's obligations and requirements are subject to certification by an external third party and review and approval by FDA...